Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer

[1] Dowsett M(2011)Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group J Natl Cancer Inst 103 1656-1664

[2] Nielsen TO(1991)Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes Cytometry 12 42-49

[3] A'Hern R(2007)Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Br J Cancer 96 1504-1513

[4] Lopez F(2014)Higher Ki67 expression is associates with unfavorable prognostic factors and shorter survival in breast cancer Asian Pac J Cancer Prev 15 1381-1385

[5] Belloc F(2011)Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment BMC Cancer 11 486-1906

[6] Lacombe F(2013)An international Ki67 reproducibility study J Natl Cancer Inst 105 1897-361

[7] Dumain P(2016)Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration NPJ Breast Cancer 2 16014-153

[8] Reiffers J(2015)An international study to increase concordance in Ki67 scoring Mod Pathol 28 778-69

[9] Bernard P(2015)Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility J Clin Pathol 68 356-118

[10] Boisseau M(2016)High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium J Pathol Clin Res 2 138-516

[1] Dowsett M(2011)Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group J Natl Cancer Inst 103 1656-1664

[2] Nielsen TO(1991)Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes Cytometry 12 42-49

[3] A'Hern R(2007)Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Br J Cancer 96 1504-1513

[4] Lopez F(2014)Higher Ki67 expression is associates with unfavorable prognostic factors and shorter survival in breast cancer Asian Pac J Cancer Prev 15 1381-1385

[5] Belloc F(2011)Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment BMC Cancer 11 486-1906

[6] Lacombe F(2013)An international Ki67 reproducibility study J Natl Cancer Inst 105 1897-361

[7] Dumain P(2016)Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration NPJ Breast Cancer 2 16014-153

[8] Reiffers J(2015)An international study to increase concordance in Ki67 scoring Mod Pathol 28 778-69

[9] Bernard P(2015)Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility J Clin Pathol 68 356-118

[10] Boisseau M(2016)High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium J Pathol Clin Res 2 138-516